Absence of clinical signs of cardiac denervation after percutaneous myocardial laser revascularization

被引:1
|
作者
Guzzetti, S
Colombo, A
Piccaluga, E
Tagliabue, L
Magatelli, R
Cantoni, G
Viecca, M
机构
[1] Osped L Sacco, I-20157 Milan, Italy
[2] Univ Milan, Osped S Paolo, Milan, Italy
关键词
coronary disease; angina; revascularization; laser; nervous automatic system;
D O I
10.1016/S0167-5273(02)00602-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Percutaneous myocardial revascularization with laser (PMR) is a catheter-based technique that has generated much interest in the treatment of patients with severe coronary artery disease. Several mechanisms have been proposed to explain the reported clinical benefits of this technique. Cardiac autonomic denervation is among these. Methods: We studied 32 consecutive patients with chronic severe angina not suitable for other revascularization approaches. Canadian Class Society (CCS) class clinical assessment, Naughton exercise stress test, and scintigraphic myocardial perfusion were evaluated before and I and 6 months after PMR. Ewing's autonomic tests, heart rate variability (HRV), and plasmatic catecholamines were assessed before revascularization in non-diabetic and diabetic patients and repeated I month after PMR in 13 non-diabetics. A psychological test was carried out before PMR to evaluate the attitude towards this new procedure. Results: All the markers of autonomic cardiac control were unmodified after the procedure. Moreover, scintigraphic perfusion measured in the lasered areas was similar before and after the procedure. On the other hand, the clinical conditions significantly improved (CCS class from 3+/-0.8 to 1.9+/-0.9 at 1 month, P<0.01) and the exercise-related ischemic threshold was significantly better (from 311+/-28 to 453+/-51 s, P<0.05). The patients with a psychologically 'positive' expectation for this new procedure had results comparable to those with a 'negative' expectation. Conclusions: PMR improves symptoms in patients with end-stage coronary artery disease in the absence of any detectable clinical sign of heart denervation. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
  • [21] After myocardial revascularization: clinical case
    Danzi, Gian Battista
    GIORNALE ITALIANO DI CARDIOLOGIA, 2005, 6 (05) : 43S - 45S
  • [22] Percutaneous transluminal myocardial revascularization with a holmium laser system: Procedural results and early clinical outcome
    Kaul, U
    Shawl, F
    Singh, B
    Sudan, D
    Sapra, R
    Ghose, T
    Dixit, NS
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 1999, 47 (03) : 287 - 291
  • [23] Percutaneous laser transmyocardial revascularization and stress/rest myocardial perfusion
    Rubini, G
    Bortone, A
    Rubini, D
    Tucci, A
    Tupputi, LD
    D'Addabbo, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1066 - 1066
  • [24] Percutaneous myocardial laser, revascularization in patients with refractory angina pectoris
    Gray, TJ
    Burns, SM
    Clarke, SC
    Tait, S
    Sharples, LD
    Caine, N
    Schofield, PM
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (06): : 661 - 666
  • [25] Myocardial scarring after transmyocardial laser revascularization: A potential mechanism of clinical improvement?
    Mueller, XM
    Tevaearai, HT
    Genton, CY
    von Segesser, LK
    LASERS IN SURGERY AND MEDICINE, 1999, 25 (01) : 79 - 87
  • [26] Effects of renal denervation on cardiac function after percutaneous coronary intervention in patients with acute myocardial infarction
    Gao, Jun-Qing
    Xu, You-Long
    Ye, Jian
    Hou, Shu-Xin
    Yang, Wei
    Li, Min
    Fa, Jing-Jing
    Yang, Cheng-Hao
    Jin, Hui -Gen
    He, Rui-Qing
    Liu, Zong-Jun
    HELIYON, 2023, 9 (07)
  • [27] Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures
    Salem, M
    Rotevatn, S
    Stavnes, S
    Brekke, M
    Pettersen, R
    Kuiper, K
    Ulvik, R
    Nordrehaug, JE
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 104 (02) : 144 - 151
  • [28] Methylenetetrahydrofolate reductase gene polymorphism and long term clinical outcome after percutaneous myocardial revascularization
    Shayne, John
    Souibri, Karam
    Le Hello, Claire
    Fradin, Sabine
    Sabatier, Remi
    Morello, Remi
    Grollier, Gilles
    Hamon, Martial
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 24M - 24M
  • [29] Sustained clinical benefit two years after percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease
    Lauer, B
    Stahl, F
    Bratanow, S
    Schuler, G
    EUROPEAN HEART JOURNAL, 2000, 21 : 174 - 174
  • [30] Sustained clinical benefit two years after percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease
    Lauer, B
    Stahl, F
    Bratanow, S
    Schuler, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 67A - 67A